SCHEMBL6638432

SCHEMBL6638432

COc1cc[c]c(CCN(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.44
HTR6 P50406 9/20 0.43
HTR2C P28335 3/20 0.43
HTR1A P08908 3/20 0.43
HTR1D P28221 3/20 0.43
HTR1E P28566 3/20 0.43
HTR7 P34969 3/20 0.43
HTR5A P47898 3/20 0.43
HTR2B P41595 2/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HTR1B P28222 1/20 0.43
HTR1F P30939 1/20 0.43
HTR3A P46098 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
HTR4 Q13639 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18706270 0.84 SLC6A4 (0.40) HTR2AHTR2CCYP2D6SLC6A2SLC6A4
SCHEMBL7400862 0.80 DRD2 (0.35) HTR6
SCHEMBL10748671 0.79 TAAR1 (0.49) HTR2AHTR6HTR2CHTR1AHTR1D
SCHEMBL7386695 0.79 CYP2D6 (0.41) CYP1A2CYP2D6SLC6A2
SCHEMBL8917172 0.79 TAAR1 (0.36) CYP1A2AOC3
SCHEMBL9053089 0.77 HRH2 (0.37) HTR2ACYP1A2CYP2D6CYP2C9L3MBTL1
SCHEMBL8183757 0.77 ALDH1A1 (0.36) HTR2ACYP1A2CYP2D6CYP2C9AOC3
SCHEMBL462206 0.76 PTGS2 (0.42) HTR2AL3MBTL1
SCHEMBL457740 0.76 CA1 (0.35) CYP1A2
SCHEMBL10612033 0.75 HTR2A (0.41) HTR2AHTR6HTR2CHTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed